MX2014006201A - Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse. - Google Patents
Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.Info
- Publication number
- MX2014006201A MX2014006201A MX2014006201A MX2014006201A MX2014006201A MX 2014006201 A MX2014006201 A MX 2014006201A MX 2014006201 A MX2014006201 A MX 2014006201A MX 2014006201 A MX2014006201 A MX 2014006201A MX 2014006201 A MX2014006201 A MX 2014006201A
- Authority
- MX
- Mexico
- Prior art keywords
- solid dosage
- before use
- dosage forms
- imatinib
- reconstituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Abstract
La presente invención se relaciona con las formulaciones farmacéuticas que comprenden imitinib en formas de dosificaciones sólidas reconstituidas con un diluyente justo antes de usarse; procesos de preparación y usos de las mismas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201111621 | 2011-11-24 | ||
PCT/TR2011/000268 WO2013077815A1 (en) | 2011-11-24 | 2011-11-30 | Imatinib solid dosage forms reconstituted just before use |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014006201A true MX2014006201A (es) | 2014-12-05 |
Family
ID=45615035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014006201A MX2014006201A (es) | 2011-11-24 | 2011-11-30 | Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150125534A1 (es) |
EP (1) | EP2782560A1 (es) |
BR (1) | BR112014012400A2 (es) |
CA (1) | CA2856692C (es) |
EA (1) | EA026665B1 (es) |
MX (1) | MX2014006201A (es) |
WO (1) | WO2013077815A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA035891B1 (ru) | 2016-01-25 | 2020-08-27 | КРКА, д.д., НОВО МЕСТО | Быстродиспергируемая фармацевтическая композиция, включающая ингибитор тирозинкиназы |
US11285152B2 (en) | 2017-07-20 | 2022-03-29 | Kashiv Biosciences, Llc | Stable oral pharmaceutical composition of imatinib |
EP3658190A1 (en) | 2017-07-26 | 2020-06-03 | FTF Pharma Private Limited | Liquid dosage forms of imatinib |
AU2020312840A1 (en) * | 2019-07-15 | 2022-01-20 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition of imatinib |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
MY148074A (en) | 2005-05-10 | 2013-02-28 | Novartis Ag | Pharmaceutical compositions comprising imatinib and a release retardant |
ES2341996T3 (es) * | 2005-06-03 | 2010-06-30 | Elan Pharma International Limited | Formulaciones de mesilato de imatinib en forma de manoparticulas. |
ATE445392T1 (de) * | 2005-08-15 | 2009-10-15 | Siegfried Generics Int Ag | Filmtablette oder granulat enthaltend ein pyridylpyrimidin |
CA2662265A1 (en) | 2006-09-01 | 2008-03-06 | Teva Pharmaceutical Industries Ltd. | Imatinib compositions |
EP1920767A1 (en) | 2006-11-09 | 2008-05-14 | Abbott GmbH & Co. KG | Melt-processed imatinib dosage form |
CA2680249A1 (en) | 2007-03-12 | 2008-09-18 | Dr. Reddy's Laboratories, Inc. | Imatinib mesylate |
ES2391625T3 (es) | 2007-06-07 | 2012-11-28 | Novartis Ag | Formas amorfas estabilizadas de mestilato de imatinib |
BRPI0817946A2 (pt) | 2007-09-25 | 2015-05-05 | Teva Pharma | Composições de imatinibe estável |
ES2476259T3 (es) * | 2007-12-27 | 2014-07-14 | Taiho Pharmaceutical Co., Ltd. | Preparación antitumoral de material particulado oral |
CA2715422A1 (en) * | 2008-03-21 | 2009-09-24 | Elan Pharma International Limited | Compositions for site-specific delivery of imatinib and methods of use |
TR200802061A2 (tr) | 2008-03-27 | 2009-07-21 | Bi̇lgi̇ç Mahmut | Yüksek oranda aktif madde içeren farmasötlk formülasyon. |
CN101401794A (zh) | 2008-11-17 | 2009-04-08 | 北京诚创康韵医药科技有限公司 | 一种甲磺酸伊马替尼咀嚼片及其制备方法 |
CN101401797A (zh) | 2008-11-17 | 2009-04-08 | 北京诚创康韵医药科技有限公司 | 一种含有甲磺酸伊马替尼的泡腾片及其制备方法 |
CN101401795A (zh) | 2008-11-17 | 2009-04-08 | 北京诚创康韵医药科技有限公司 | 一种甲磺酸伊马替尼口腔崩解片及其制备方法 |
WO2011095835A1 (en) * | 2010-02-02 | 2011-08-11 | Actavis Group Ptc Ehf | Highly pure imatinib or a pharmaceutically acceptable salt thereof |
-
2011
- 2011-11-30 US US14/359,905 patent/US20150125534A1/en not_active Abandoned
- 2011-11-30 EP EP11818957.0A patent/EP2782560A1/en not_active Withdrawn
- 2011-11-30 CA CA2856692A patent/CA2856692C/en not_active Expired - Fee Related
- 2011-11-30 EA EA201400609A patent/EA026665B1/ru not_active IP Right Cessation
- 2011-11-30 WO PCT/TR2011/000268 patent/WO2013077815A1/en active Application Filing
- 2011-11-30 BR BR112014012400A patent/BR112014012400A2/pt not_active IP Right Cessation
- 2011-11-30 MX MX2014006201A patent/MX2014006201A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EA026665B1 (ru) | 2017-05-31 |
WO2013077815A1 (en) | 2013-05-30 |
BR112014012400A2 (pt) | 2017-06-13 |
EA201400609A1 (ru) | 2014-09-30 |
EP2782560A1 (en) | 2014-10-01 |
CA2856692A1 (en) | 2013-05-30 |
US20150125534A1 (en) | 2015-05-07 |
CA2856692C (en) | 2016-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
MX364229B (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
GB201106750D0 (en) | Novel compounds | |
IL227625A0 (en) | Nanoparticle compounds, their formulations, and their use | |
IL227626A0 (en) | A compound of 17-il and γ-ifn inhibitors, preparations containing them and their uses | |
EP2746283A4 (en) | PYRIMIDOPYRIMIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES | |
IL230463A (en) | Benzamides, their preparation and their pharmaceutical preparations | |
IN2015DN03327A (es) | ||
IN2015DN03984A (es) | ||
JO3154B1 (ar) | عوامل مضادة لـ trpv4 | |
AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
PH12014501565A1 (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
MX357284B (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
IL233825A (en) | H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines | |
HK1207288A1 (en) | Itraconazole compositions and dosage forms, and methods of using the same | |
HK1208188A1 (en) | Formulations for the delivery of active ingredients | |
MX2014006201A (es) | Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse. | |
EP2784061A4 (en) | ACYLHYDRACO AND OXADIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF | |
HK1189355A1 (zh) | 包含阿那白滯素的無檸檬酸鹽藥物組合物 | |
EP2933290A4 (en) | COMPOSITION FOR COMPLEX FORMATION, COMPLEX FORMED THEREFROM, AND COMPOSITION FOR ORAL ADMINISTRATION COMPRISING SAID COMPLEX | |
WO2012093973A3 (en) | Compositions in the form of tablets comprising acarbose | |
WO2013074048A3 (en) | Tablet forms comprising quetiapine fumarate | |
IN2012DE00826A (es) | ||
EP2926811A4 (en) | ARTEMISCULAR PHARMACEUTICAL COMPOSITION, MANUFACTURE AND USE |